Vita Life Sciences Ltd (VLS) — Capital Reinvestment Ratio
Vita Life Sciences Ltd (VLS) has a Capital Reinvestment Ratio of 0.11x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$6.60 Million) in capital expenditures (AU$730.00K). Check VLS goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vita Life Sciences Ltd Capital Reinvestment Ratio (2006–2024)
This chart tracks Vita Life Sciences Ltd's Capital Reinvestment Ratio across 17 annual periods. For the full cash flow conversion analysis, see VLS cash flow metrics.
Annual Capital Reinvestment Ratio for Vita Life Sciences Ltd (2006–2024)
Year-by-year Capital Reinvestment Ratio for Vita Life Sciences Ltd from 2006 to 2024. See VLS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.03x | AU$6.16 Million | AU$198.00K | ▼ -36.7% |
| 2023 | 0.05x | AU$12.98 Million | AU$660.00K | ▲ +1.5% |
| 2022 | 0.05x | AU$2.77 Million | AU$139.00K | ▲ +90.3% |
| 2021 | 0.03x | AU$5.89 Million | AU$155.00K | ▲ +123.1% |
| 2020 | 0.01x | AU$7.54 Million | AU$89.00K | ▼ -95.9% |
| 2019 | 0.29x | AU$2.03 Million | AU$579.00K | ▲ +118.1% |
| 2018 | 0.13x | AU$2.84 Million | AU$372.00K | ▲ +118.2% |
| 2017 | 0.06x | AU$3.22 Million | AU$193.00K | ▼ -87.3% |
| 2016 | 0.47x | AU$4.71 Million | AU$2.23 Million | ▲ +165.2% |
| 2015 | 0.18x | AU$4.92 Million | AU$879.00K | ▼ -83.9% |
| 2014 | 1.11x | AU$6.12 Million | AU$6.78 Million | ▲ +1820.9% |
| 2013 | 0.06x | AU$4.83 Million | AU$279.00K | ▼ -32.9% |
| 2012 | 0.09x | AU$1.38 Million | AU$119.00K | ▲ +581.4% |
| 2011 | 0.01x | AU$5.66 Million | AU$71.49K | ▼ -90.6% |
| 2008 | 0.13x | AU$567.42K | AU$76.53K | ▼ -46.1% |
| 2007 | 0.25x | AU$750.00K | AU$187.60K | ▼ -44.8% |
| 2006 | 0.45x | AU$516.00K | AU$234.00K | — |